191.021 articles found

Considerations for expanding community exercise programs incorporating a healthcare-recreation partnership for people with balance and mobility limitations: a mixed methods evaluation.

Salbach NM, Howe JA, Baldry D, Merali S, Munce SEP.

BMC Res Notes · 2018-04-02

DOI: 10.1186/s13104-018-3313-xPMID: 29609662

Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data.

Hussain G, Zhang L, Rasul A, Anwar H, Sohail MU, Razzaq A, Aziz N, Shabbir A, Ali M, Sun T.

Molecules · 2018-04-02

DOI: 10.3390/molecules23040814PMID: 29614843

Technical Case Report of Deep Brain Stimulation: Is it Possible Single Electrode Reach to Both of Subthalamic Nucleus and Ventral Intermediate Nucleus in One Stage?

Kaptan H, Çakmur R.

Open Access Maced J Med Sci · 2018-04-02

DOI: 10.3889/oamjms.2018.137PMID: 29731935

Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease.

Maass F, Michalke B, Leha A, Boerger M, Zerr I, Koch JC, Tönges L, Bähr M, Lingor P.

J Neurochem · 2018-04-02

DOI: 10.1111/jnc.14316PMID: 29388213

Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders.

Fleisher J, Barbosa W, Sweeney MM, Oyler SE, Lemen AC, Fazl A, Ko M, Meisel T, Friede N, Dacpano G, Gilbert RM, Di Rocco A, Chodosh J.

J Am Geriatr Soc · 2018-04-02

DOI: 10.1111/jgs.15337PMID: 29608779

King's Parkinson's Disease Pain Scale for Assessment of Pain Relief Following Deep Brain Stimulation for Parkinson's Disease.

DiMarzio M, Pilitsis JG, Gee L, Peng S, Prusik J, Durphy J, Ramirez-Zamora A, Hanspal E, Molho E, McCallum SE.

Neuromodulation · 2018-04-02

DOI: 10.1111/ner.12778PMID: 29608802

Response to "Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms".

Horne KL, Myall DJ, MacAskill MR, Anderson TJ, Dalrymple-Alford JC.

Int Psychogeriatr · 2018-04-02

DOI: 10.1017/s1041610218000091PMID: 29606167

Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms clarification letter.

Camicioli R, Mcdermott K.

Int Psychogeriatr · 2018-04-02

DOI: 10.1017/s104161021800008xPMID: 29606172

Nociceptive Response to L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.

Nascimento GC, Bariotto-Dos-Santos K, Leite-Panissi CRA, Del-Bel EA, Bortolanza M, Bortolanza M.

Neurotox Res · 2018-04-02

DOI: 10.1007/s12640-018-9896-0PMID: 29611150

S221. QUANTITATIVE SYSTEMS PHARMACOLOGY AS AN ALTERNATIVE TO CHLORPROMAZINE EQUIVALENTS: PREDICTIVE VALIDATION FROM A CRIS DATABASE EXPERIMENT

Geerts H, Spiros A, Kadra G, Stewart R, Hayes R, Shetty H, Iqbal E.

Schizophrenia bulletin · 2018-04-01

F205. OLFACTORY IDENTIFICATION IN 7-YEAR OLD CHILDREN AT FAMILIAL RISK TO DEVELOP SCHIZOPHRENIA

van Themaat A, Jepsen J, Christiani C, Nordentoft M.

Schizophrenia bulletin · 2018-04-01

T106. IMPROVING PSYCHIATRIC DIAGNOSIS BY ADDING MOTOR FUNCTION NEXT TO MENTAL HEALTH FUNCTION: A NETWORK APPROACH

Noviar G, Rhebergen D, Roberto Bakker P.

Schizophrenia bulletin · 2018-04-01